| Date Filed | Type | Description |
| 10/02/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 3,000 shares
@ $7.7198, valued at
$23.2k
Exercised 3,000 options to buy
@ $1.06, valued at
$3.2k
|
|
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 5,378 shares
@ $9.18, valued at
$49.4k
|
|
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/03/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 3,000 shares
@ $7.49, valued at
$22.5k
Exercised 3,000 options to buy
@ $1.06, valued at
$3.2k
|
|
| 06/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 3,000 shares
@ $8.6294, valued at
$25.9k
Exercised 3,000 options to buy
@ $1.06, valued at
$3.2k
|
|
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 5,415 shares
@ $5.6, valued at
$30.3k
|
|
| 02/27/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,000 shares
@ $7.8175, valued at
$62.5k
Exercised 8,000 options to buy
@ $1.06, valued at
$8.5k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,000 shares
@ $8.0684, valued at
$64.5k
Exercised 8,000 options to buy
@ $1.06, valued at
$8.5k
|
|
| 12/30/2022 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,000 shares
@ $7.6958, valued at
$61.6k
Exercised 8,000 options to buy
@ $1.06, valued at
$8.5k
|
|
| 11/17/2022 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,453 shares
@ $11.86, valued at
$17.2k
Sold 16,000 shares
@ $10.9626, valued at
$175.4k
Exercised 16,000 options to buy
@ $1.06, valued at
$17k
|
|
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 15,936 shares
@ $10.8566, valued at
$173k
Sold 64 shares
@ $11.53, valued at
$737.9
Exercised 16,000 options to buy
@ $1.06, valued at
$17k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Exercised 4,000 options to buy
@ $1.06, valued at
$4.2k
|
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 1,798 shares
@ $18.8145, valued at
$33.8k
Sold 702 shares
@ $19.2015, valued at
$13.5k
|
|
| 04/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |